Selective inhibition of cytoplasmic HDAC6 by the HDAC6 inhibitor 34 (Figure 5, marbostat) led to MYC degradation and apoptosis in MYC-overexpressing B-cell lymphoma cells. Here, MYC is linked to B-cell non-Hodgkin lymphoma.